2019 ASM – Speaker Presentations
Bronwyn Morrish – National Cervical Screening Program
Cath Adams – Psychological Issues in Cervical Cancer
Dr Chris Milross – Are we radical enough in fully staged intermediate risk endometrial cancer patients?
Christina Fotopoulou – Evolution of surgery in gynaecological cancer over the last decades – Where are we now?
Christina Fotopoulou – HIPEC for ovarian cancer: HYPE or HOPE?
Dr Christina Mapagu – Homologous recombination deficiency (HRD) Testing in ovarian cancer: Aiming to increase the clinical utility of parp inhibitors
Dr Dane Cheasley – Genomic analysis of low-grade serous ovarian cancer reveals unique therapeutic vulnerabilities
David Wrede – Cervical cancer prevention & screening – HPV testing & vaccination a global perspective
Dr Elaine Sanji – Activation of targeted DNA damage response as a novel therapeuticstrategy for ovarian cancer
Dr Emily Colvin – Characterisation and targeting of Cancer-Associated Fibroblasts in High Grade Serous
Dr Eryn Dow – Germline Genetic Contributions to Endometriosis-Associated Ovarian Cancer: A Gene Discovery Project
Dr Helen Gooden – Survivors Teaching Students: Update 2019
Prof John Hooper – Efficacy of carboplatin against Clear Cell Ovarian Carcinoma is improved by inhibition of glycogen utilisation
Dr Kylie Gorringe – P Mucinous ovarian cancer is distinct from extra-ovarian metastases and evolves from benign and borderline precursors.
Dr Kylie Gorringe – Therapeutic opportunities for mucinous ovarian carcinoma
Prof Lewis Perrin – HIPEC – New service Mater Hospital Brisbane
Assoc Prof Linda Mileshkin – Pushing the bar in endometrial cancer treatment: What’s next?
Madeleine King – SPIRIT-PRO Checklist
Dr Michelle Harrison – Metastatic cervical and vulva cancer: where are the trials taking us?
Dr Michelle Harrison – Case Presentation 2
Dr Michelle Vaughan – Adjuvant chemotherapy in uterine cancer
Ms Nicole Meagher – Diagnosing mucinous ovarian cancer – is there a role for SATB2?
Nigel McMillan – Treating cervical cancer with gene editing.
Nisha Jaquasia – SLN mapping in early stage endometrial cancer during minimally invasive surgery
Assoc Prof Orla McNally – The role of Sentinel Lymph Node Biopsy in High Risk Endometrial Cancer
Paul Cohen – Getting the MOST out of Ovarian Cancer Follow-Up
Paul Cohen – EXcisional treatment Comparison for In Situ Endocervical adenocarcinoma
Prof Penelope Webb – Statin use and survival after a diagnosis of endometrial cancer: a national data-linkage study
Prof Penelope Schofield – Peer support after radiotherapy treatment with curative intent for gynaecological cancer : The PeNTAGOn Study
Prof Peter Hoffman – Proteomics and Mass Spectrometry Imaging on gynaecological cancer tissue
Quality & Survivorship – Quality of life – A radical perspective
Dr Rhonda Farrell – HIPEC for ovarian cancer and the Australian/ New Zealand perspective
Dr Sherry Wu – Re-activating Anti-tumour Immunity in Ovarian Cancer using Non-coding RNAs
Dr Stephen Wong – Clinical implementation of circulating tumour DNA analysis for personalised oncology: From blocks to blood
Dr Tracey O’Mara
Dr Umesh Mahantshetty – “An Update and Challenges” in Treatment of GYN (Cervical) Cancers A Radiation Oncologist’s Perspective!
Dr Umesh Mahantshetty – Optimizing Radiation To Groin Nodes in Vulvar Cancer
Dr Umesh Mahantshetty – Managing patients with Vulvar cancer In Low – resources settings At Tata Memorial Hospital Mumbai
Assoc Prof Winston Liauw – Diffusion or perfusion of Innovation: The case for HIPEC in Ovarian Cancer
Receive our bi-annual ResearcHER newsletter and invitation to local community events